• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者静脉血栓栓塞的特征与影响

Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma.

作者信息

Wang Yuchen, Attar B M, Hinami K, Fuentes H E, Jaiswal P, Zhang H, Simons-Linares C S, Tafur A J

机构信息

Department of Internal Medicine, John H. Stroger, Jr. Hospital of Cook County, 1900 West Polk Street, Chicago, IL, 60612, USA.

Division of Gastroenterology and Hepatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA.

出版信息

J Gastrointest Cancer. 2018 Sep;49(3):275-282. doi: 10.1007/s12029-017-9945-6.

DOI:10.1007/s12029-017-9945-6
PMID:28374272
Abstract

INTRODUCTION

Venous thromboembolism (VTE) is a common complication in cancer patients, and is associated with worse prognosis in such population. Hepatocellular carcinoma (HCC) poses high risk for VTE; however, data is scarce regarding the characteristics and consequences of VTE in HCC patients.

METHOD

We retrospectively reviewed the electronic medical records (EMR) of 270 patients diagnosed with HCC from 2000 to 2015 in Cook County Health and Hospitals System. We report the cumulative incidence of VTE in the present cohort, and identified through multivariate logistic regression the independent risk factors of the development of VTE. Overall prognosis of patients with and without VTE were presented and compared.

RESULTS

Sixteen cases (5.93%) of VTE were documented in the present study. In multivariate analysis, obesity, Child B cirrhosis, intra-hepatic lesions more than 3, and multi-organ extrahepatic metastasis were significantly associated with VTE development (p < 0.05). The presence of VTE was an independent risk factor for mortality in multivariate analysis (HR = 3.62, p = 0.021), together with male gender, Child C cirrhosis, and extrahepatic metastasis.

CONCLUSIONS

Obesity, Child B cirrhosis, more intra-hepatic lesions, and multi-organ extrahepatic metastasis are associated with cancer-associated VTE. VTE will adversely affect the prognosis of patients with HCC; therefore, primary thromboprophylaxis may be warranted in such population.

摘要

引言

静脉血栓栓塞症(VTE)是癌症患者常见的并发症,且与该人群的不良预后相关。肝细胞癌(HCC)患者发生VTE的风险较高;然而,关于HCC患者VTE的特征和后果的数据却很匮乏。

方法

我们回顾性分析了2000年至2015年在库克县卫生和医院系统诊断为HCC的270例患者的电子病历(EMR)。我们报告了本队列中VTE的累积发病率,并通过多因素逻辑回归确定了VTE发生的独立危险因素。呈现并比较了有和没有VTE的患者的总体预后。

结果

本研究记录了16例(5.93%)VTE病例。在多因素分析中,肥胖、Child B级肝硬化、肝内病变超过3个以及多器官肝外转移与VTE的发生显著相关(p<0.05)。在多因素分析中,VTE的存在是死亡率的独立危险因素(HR=3.62,p=0.021),此外还有男性、Child C级肝硬化和肝外转移。

结论

肥胖、Child B级肝硬化、更多的肝内病变以及多器官肝外转移与癌症相关的VTE有关。VTE会对HCC患者的预后产生不利影响;因此,在此类人群中可能有必要进行一级血栓预防。

相似文献

1
Characteristics and Impacts of Venous Thromboembolism in Patients with Hepatocellular Carcinoma.肝细胞癌患者静脉血栓栓塞的特征与影响
J Gastrointest Cancer. 2018 Sep;49(3):275-282. doi: 10.1007/s12029-017-9945-6.
2
Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.霍纳纳风险评分对肝细胞癌患者静脉血栓栓塞的预测效能
Clin Appl Thromb Hemost. 2018 Apr;24(3):471-476. doi: 10.1177/1076029617699088. Epub 2017 Mar 14.
3
Correlates, Trends, and Short-Term Outcomes of Venous Thromboembolism in Hospitalized Patients with Hepatocellular Carcinoma.肝细胞癌住院患者静脉血栓栓塞的相关因素、趋势及短期结局
J Gastrointest Cancer. 2019 Jun;50(2):357-360. doi: 10.1007/s12029-019-00242-9.
4
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.美国门诊高危癌症患者化疗期间静脉血栓栓塞症(VTE)的发生率及预测因素。
Cancer. 2013 Feb 1;119(3):648-55. doi: 10.1002/cncr.27772. Epub 2012 Aug 14.
5
Venous thromboembolism in uterine cancer.子宫癌中的静脉血栓栓塞症。
Int J Gynecol Cancer. 2011 Jul;21(5):870-6. doi: 10.1097/IGC.0b013e31821a367e.
6
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.肝硬化肝细胞癌肝切除的预后因素:单因素和多因素分析
J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178.
7
Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients.一大群住院肝硬化患者门静脉血栓形成或静脉血栓栓塞的危险因素
Intern Emerg Med. 2022 Aug;17(5):1327-1334. doi: 10.1007/s11739-022-02928-8. Epub 2022 Jan 25.
8
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.活动性癌症患者首次及复发性静脉血栓栓塞的流行病学。一项基于人群的队列研究。
Thromb Haemost. 2017 Jan 5;117(1):57-65. doi: 10.1160/TH15-08-0686. Epub 2016 Oct 6.
9
Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.急性后期护理患者静脉血栓栓塞症的发生率及预测因素。一项前瞻性队列研究。
Thromb Haemost. 2010 Oct;104(4):734-40. doi: 10.1160/TH10-03-0169. Epub 2010 Jul 20.
10
Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.肺癌患者中偶然发现和临床疑似静脉血栓栓塞症的流行率和临床意义。
Clin Lung Cancer. 2013 Nov;14(6):713-8. doi: 10.1016/j.cllc.2013.06.003. Epub 2013 Jul 26.

引用本文的文献

1
Incidence of thrombosis in patients with hepatocellular carcinoma: systematic review and meta-analysis.肝细胞癌患者血栓形成的发生率:系统评价与荟萃分析。
J Thromb Thrombolysis. 2025 Jul 5. doi: 10.1007/s11239-025-03143-w.
2
A nomogram predicting venous thromboembolism risk in primary liver cancer patients.一种预测原发性肝癌患者静脉血栓栓塞风险的列线图。
J Thromb Thrombolysis. 2025 Jan;58(1):145-156. doi: 10.1007/s11239-024-03041-7. Epub 2024 Sep 21.
3
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.

本文引用的文献

1
Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study.意大利南部地区肝炎病毒感染、FIB-4指数与肝细胞癌风险:一项基于人群的队列研究
Infect Agent Cancer. 2016 Nov 3;11:54. doi: 10.1186/s13027-016-0101-x. eCollection 2016.
2
Trends in Hospitalization and Mortality of Venous Thromboembolism in Hospitalized Patients With Colon Cancer and Their Outcomes: US Perspective.住院的结肠癌患者静脉血栓栓塞症的住院和死亡率趋势及其结局:美国视角。
Clin Colorectal Cancer. 2017 Sep;16(3):e199-e204. doi: 10.1016/j.clcc.2016.09.006. Epub 2016 Sep 20.
3
肝硬化伴 HCC 与不伴 HCC 患者的高凝状态和低纤维蛋白溶解更为明显。
Hepatol Commun. 2021 Dec;5(12):1987-2000. doi: 10.1002/hep4.1781. Epub 2021 Aug 16.
4
Correlates, Trends, and Short-Term Outcomes of Venous Thromboembolism in Hospitalized Patients with Hepatocellular Carcinoma.肝细胞癌住院患者静脉血栓栓塞的相关因素、趋势及短期结局
J Gastrointest Cancer. 2019 Jun;50(2):357-360. doi: 10.1007/s12029-019-00242-9.
5
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma.肝细胞癌肝硬化患者的癌症相关血栓形成
Cancers (Basel). 2018 Nov 16;10(11):450. doi: 10.3390/cancers10110450.
6
NRAL mediates cisplatin resistance in hepatocellular carcinoma via miR-340-5p/Nrf2 axis.NRAL通过miR-340-5p/Nrf2轴介导肝细胞癌中的顺铂耐药。
J Cell Commun Signal. 2019 Mar;13(1):99-112. doi: 10.1007/s12079-018-0479-x. Epub 2018 Jul 20.
7
Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma.血小板与淋巴细胞比值对肝细胞癌患者的预后价值评估。
J Gastrointest Oncol. 2017 Dec;8(6):1065-1071. doi: 10.21037/jgo.2017.09.06.
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.
癌症患者偶然发现肺栓塞时的抗凝治疗期间和之后的结果。
Eur Respir J. 2016 Nov;48(5):1360-1368. doi: 10.1183/13993003.00779-2016. Epub 2016 Sep 22.
4
Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.活动性癌症血栓栓塞结局的预测因素:肺癌患者中Khorana评分的验证
J Thromb Haemost. 2016 Sep;14(9):1773-8. doi: 10.1111/jth.13378. Epub 2016 Sep 9.
5
Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.肺癌患者静脉血栓栓塞的风险:一项使用英国医疗保健关联数据的队列研究。
Br J Cancer. 2016 Jun 28;115(1):115-21. doi: 10.1038/bjc.2016.143. Epub 2016 Jun 2.
6
Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study.东亚人群胰腺腺癌患者静脉血栓栓塞的特征:一项基于大样本人群的观察性研究
Medicine (Baltimore). 2016 Apr;95(17):e3472. doi: 10.1097/MD.0000000000003472.
7
Cancer-associated thrombosis.癌症相关血栓形成
Dis Mon. 2016 May;62(5):121-58. doi: 10.1016/j.disamonth.2016.03.003. Epub 2016 Mar 29.
8
Venous thromboembolism in brain tumor patients.脑肿瘤患者的静脉血栓栓塞
J Clin Neurosci. 2016 Mar;25:13-8. doi: 10.1016/j.jocn.2015.05.053. Epub 2015 Nov 17.
9
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.在1期临床试验中,严重肝功能不全与静脉血栓栓塞事件相关。
Thromb Res. 2015 Dec;136(6):1169-73. doi: 10.1016/j.thromres.2015.10.024. Epub 2015 Oct 20.
10
Prognostic significance of arterial and venous thrombosis in resected specimens for non-small cell lung cancer.切除标本中非小细胞肺癌中动静脉血栓形成的预后意义。
Thromb Res. 2015 Aug;136(2):451-5. doi: 10.1016/j.thromres.2015.06.014. Epub 2015 Jun 14.